Austin, TX, United States of America

Stephanie Volz

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stephanie Volz

Introduction

Stephanie Volz is a distinguished inventor based in Austin, TX, recognized for her significant contributions to the field of biomedical research and diagnostics. With two patents to her name, she has been at the forefront of developing innovative solutions that enhance disease diagnosis and monitoring.

Latest Patents

Stephanie Volz's latest patents focus on the use of microRNAs (miRNAs) as biomarkers for various diseases. Her first patent, "MiRNA biomarkers of lung disease," describes the potential of miRNAs in serum or plasma to characterize lung disease in patients. This innovative approach holds promise for improving the diagnosis, prognosis, and monitoring of conditions such as lung cancer. Similarly, her second patent, "MiRNA biomarkers of prostate disease," outlines the application of miRNAs for characterizing prostate disease. These biomarkers also serve as critical tools for the diagnosis and management of prostate cancer.

Career Highlights

As a key member of Asuragen, Inc., Stephanie has dedicated her career to advancing molecular diagnostics. Her work showcases her commitment to leveraging cutting-edge research to develop practical solutions in the medical field. The impact of her inventions is poised to revolutionize how diseases are diagnosed and monitored, providing tailored approaches for patient care.

Collaborations

Throughout her career, Stephanie Volz has collaborated with esteemed colleagues such as David Allen Brown and Alex Adai. These partnerships have fostered a rich environment for innovation, allowing for the pooling of expertise and resources to enhance research outcomes in the domain of molecular diagnostics.

Conclusion

In conclusion, Stephanie Volz continues to be a trailblazer in the field of biomedical innovation. Her groundbreaking patents on miRNA biomarkers underscore her role in transforming diagnostic practices. As her work progresses, she is set to leave an indelible mark on the healthcare landscape, emphasizing the importance of early and accurate disease detection.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…